Accell Clinical Research is an international full-service Contract Research Organization (CRO) founded in 2007 with the slogan "Recruit patients on time. Every time." The company specializes in managing Phase I-III clinical trials across Europe and Eurasia, boasting a strong local presence and the capability to recruit patients in post-Soviet countries. With a focus on providing fast patient recruitment in 20+ countries in the region, Accell offers a wide range of services for clinical trials, including strategic guidance, project management, clinical and medical monitoring, data management, and quality assurance.
Accell Clinical Research caters to various therapeutic areas such as Oncology, Cardiovascular, Immunology, Gastroenterology, Neurology, and Endocrinology. Their direct capabilities in Europe & Eurasia set them apart in the industry. Despite the absence of recent disclosed investments, the company's expertise in patient recruitment and its extensive range of services make it a key player in the Health Care sector, particularly in the realm of clinical research. With its established track record and broad geographic coverage, Accell presents an attractive opportunity for potential investors seeking exposure in the clinical trials market.